Global burden of cardiovascular diseases attributable to hypertension in young adults from 1990 to 2019
Open accessThe DOI matches its Crossref record; 36 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Hypertension grows into a serious public health problem among young adults, linking to a set of life-threatening cardiovascular diseases (CVDs). Young adults are not well represented in current knowledge about the CVDs burden attributable to hypertension. METHODS: In this analysis of data from the GBD (Global Burden of Disease) study 2019, we focus on young adults and provide the first comprehensive and comparative assessment of the hypertension attributable CVDs burden, in terms of its mortality and years of living with disability (YLD) from 1990 to 2019, stratified by location, sex, and development status. RESULTS: Globally in 2019, the death and YLD numbers caused by hypertension-related CVDs were 640 239 and 2 717 474 in young adults, marking a 43.0 and 86.6% increase from 1990, respectively. The corresponding mortality rate dropped by 10.5%, whereas the YLD rate increased by 16.8% during the same period. V-shaped association between CVDs burden and social development status was observed. The largest burden and the most pronounced increase were borne by middle-income countries, while high-income countries had the lowest death/YLD rate with a quicker annual decline. Men largely outpaced women in hypertension attributable CVDs mortality. Ischemic heart disease and stroke were the leading cause for death and YLD burden, correspondingly. CONCLUSIONS: Hypertension attributable CVDs burden in young adults has greatly increased from 1990 to 2019, with considerably spatiotemporal and sexual heterogeneity. The largest burden was borne by middle-income countries, especially by men. Establishment of geographically and sexually tailored strategies were needed to prevent hypertension-related CVDs in young adults.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Roth, G. A., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32203-7 · Cited by 8,600
Rudd, K. E., Johnson, S. C., Agesa, K. M., Shackelford, K. A., Tsoi, D., Kievlan, D. R., Colombara, D. V., Ikuta, K. S., Kissoon, N., Finfer, S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32989-7 · Cited by 7,971
Forouzanfar, M. H., Afshin, A., Alexander, L. T., Anderson, H. R., Bhutta, Z. A., Biryukov, S., Brauer, M., Burnett, R., Cercy, K., Charlson, F. J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31679-8 · Cited by 7,698
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Bikbov, B., Purcell, C. A., Levey, A. S., Smith, M., Abdoli, A., Abebe, M., Adebayo, O. M., Afarideh, M., Agarwal, S. K., Agudelo-Botero, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30045-3 · Cited by 6,648
Stanaway, J. D., Afshin, A., Gakidou, E., Lim, S. S., Abate, D., Abate, K. H., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32225-6 · Cited by 4,943
The global epidemiology of hypertension
Mills, K. T., Stefanescu, A., & He, J. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0244-2 · Cited by 4,133
Mills, K. T., Bundy, J. D., Kelly, T. N., Reed, J. E., Kearney, P. M., Reynolds, K., Chen, J., & He, J. (2016) · Circulation · doi:10.1161/circulationaha.115.018912 · Cited by 3,531 · cited 1×
“Also, men have a more unfavorable CVDs risk factor profile [32], and the disparities in behavioral and metabolic risk factors largely drive the sex difference in hypertension and CVDs [33].”
Zhou, B., Bentham, J., Di Cesare, M., Bixby, H., Danaei, G., Cowan, M. J., Paciorek, C. J., Singh, G., Hajifathalian, K., Bennett, J. E., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31919-5 · Cited by 2,579
Self-citationGlobal Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015
Forouzanfar, M. H., Liu, P., Roth, G. A., Ng, M., Biryukov, S., Marczak, L., Alexander, L., Estep, K., Hassen Abate, K., Akinyemiju, T. F., et al. (2017) · JAMA · doi:10.1001/jama.2016.19043 · Cited by 2,381 · cited 2×
“Framework and definition According to the GBD 2015 comparative risk assessment study [10], ESBP was defined as the SBP of at least 110– 115 mmHg, a level that is associated with an increased risk of ischemic heart disease (IHD) and stroke [11].”
Cited by
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
Sun, J., Qiao, Y., Zhao, M., Magnussen, C. G., & Xi, B. (2023) · BMC Medicine · doi:10.1186/s12916-023-02925-4 · Cited by 281
Hypertension in China: epidemiology and treatment initiatives
Wang, J.-G., Zhang, W., Li, Y., & Liu, L. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00829-z · Cited by 176
Zhou, N., Xie, Z.-P., Liu, Q., Xu, Y., Dai, S.-C., Lu, J., Weng, J., & Wu, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1097228 · Cited by 87
Chen, W., Li, Z., Zhao, Y., Chen, Y., & Huang, R. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002839 · Cited by 92
Metadata
- Authors
- Liu, J., Bu, X., Wei, L., Wang, X., Lai, L., Dong, C., Ma, A., & Wang, T.
- Affiliations
- Department of Cardiovascular Medicine
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
- Washington University in St. Louis (US)
- Corresponding author
- Wang, Xiqiang
- Ma, Aiqun
- Wang, Tingzhong
- Venue
- Journal of Hypertension
- Published
- 2021-07-15
- Volume
- 39
- Issue
- 12
- Pages
- 2488-2496
- ISSN
- 0263-6352 (ISSN-L)
- 1473-5598
- OpenAlex
- W3177801553
- Semantic Scholar
- cdd05cfaf8c5de90f771acd00730bbb9fbd551f8
- Cited by
- 100
- References
- 40
- Citations by year
- 2026: 13 · 2025: 27 · 2024: 25 · 2023: 23 · 2022: 12
- FWCI
- 10.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Hypertension (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Health and Epidemiology
- Keywords
- hypertension, cardiovascular disease, young adults, global burden of disease, cardiovascular mortality, ischemic heart disease, stroke, sex differences, middle-income countries, temporal trends
- MeSH terms
- Global Burden of Disease, Cardiovascular Diseases, Female, Persons with Disabilities, Humans, Hypertension, Male, Global Health, Quality-Adjusted Life Years, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Global burden of cardiovascular diseases attributable to hypertension in young adults from 1990 to 2019. https://app.cochat.ai/papers/10.1097/hjh.0000000000002958
- The paper
- Liu, J., Bu, X., Wei, L., Wang, X., Lai, L., Dong, C., Ma, A., & Wang, T. (2021). Global burden of cardiovascular diseases attributable to hypertension in young adults from 1990 to 2019. Journal of Hypertension. https://doi.org/10.1097/hjh.0000000000002958
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.